Trials / Unknown
UnknownNCT04421872
The Disorder of Circadian Clock Gene and Early Cognitive Dysfunction After General Anesthesia
The Relationship Between the Disorder of Circadian Clock Gene and Early Cognitive Dysfunction After General Anesthesia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- Shengjing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
Postoperative cognitive dysfunction (POCD) is a common postoperative complication in patients aged 65 and over, which refers to cognitive function changes such as memory decline and attention deficit after anesthesia and surgery. In severe cases, personality changes and social behavior decline may also occur, resulting in irreversible cognitive impairment.Previous studies have suggested that cognitive dysfunction after general anesthesia is linked to a genetic disorder of the body clock.Exosomes are cellular forms of cellular microvesicles containing complex RNA and proteins.Exosomes can mediate the expression of genes in the late transcriptional period of the clock system, and directly or indirectly participate in the negative regulation of rhythm expression of minute control genes, playing an important role in the intercellular circadian rhythm information output pathway.Rhythm disorders in the core biological clock system of urinary exosomes and the clock control genes related to kidney can early indicate circadian rhythm changes in the core biological clock system.The sorting and detection of urinary exosome clock information materials in patients has the advantages of easy access, continuous monitoring, early diagnosis and less damage, making urinary exosome a biomarker for the diagnosis and monitoring of circadian rhythm of a good kidney biological clock system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | receiving general anesthesia | patients receiving surgery under general anesthesia |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2022-07-31
- Completion
- 2023-12-31
- First posted
- 2020-06-09
- Last updated
- 2020-06-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04421872. Inclusion in this directory is not an endorsement.